[Precautions for Neurosurgeons in Administering Anti-Amyloid β Antibody Therapy]. — In Japan, anti-amyloid β (Aβ) monoclonal antibodies, including lecanemab and donanemab, have recently been approved as disease-modifying therapies for early-stage Alzheimer's disease (AD). These drugs, developed based on the amyloid...

Evidence span

[Precautions for Neurosurgeons in Administering Anti-Amyloid β Antibody Therapy]. — In Japan, anti-amyloid β (Aβ) monoclonal antibodies, including lecanemab and donanemab, have recently been approved as disease-modifying therapies for early-stage Alzheimer's disease (AD). These drugs, developed based on the amyloid...

From Shichijo F 2025, No shinkei geka. Neurological surgery

Method & conditions

Evidence type

experimental

Method

manual state transition; control details require source inspection

Species

Homo sapiens

Conditions

Humans; Alzheimer Disease; Antibodies, Monoclonal; Amyloid beta-Peptides; Neurosurgeons — No shinkei geka. Neurological surgery 2025

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required